Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PHARMO Institute for Drug Outcomes Research is a leading Dutch research organization specializing in pharmacoepidemiology and real-world evidence (RWE). The institute maintains the PHARMO Database Network, which links multiple healthcare registries in the Netherlands to provide comprehensive longitudinal data on drug use, safety, and effectiveness. They provide services to pharmaceutical companies, regulatory authorities, and academic institutions, focusing on post-authorization safety studies (PASS), drug utilization research, and health outcomes. By leveraging high-quality real-world data, PHARMO helps stakeholders understand the impact of medicines in daily clinical practice. The institute is recognized for its rigorous methodology and extensive experience in multi-database studies across Europe.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PHARMO Institute for Drug Outcomes Research.